+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons



Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons



Antiviral Therapy 9(6): 1003-1011



There is currently an urgent need to identify effective antiviral agents that will prevent and treat severe acute respiratory syndrome coronavirus (SARS-CoV) infection. In this study, we have investigated and compared the antiviral effect of different interferons (IFNs) on SARS-CoV replication in the epithelial kidney monkey Vero cell line. The results showed that SARS-CoV grown in Vero cells is moderately sensitive to IFN-beta and only weakly sensitive to IFN-alpha and IFN-gamma, in comparison to other IFN-sensitive viruses, such as those for encephalomyocarditis, vesicular stomatitis and Newcastle disease. Simultaneous incubation of Vero cells with IFN-beta and IFN-gamma indicated that they may act synergistically against SARS-CoV replication. The IFN-induced MxA protein was detected in the IFN-treated Vero cells. The data, however, suggest that the antiviral activity of IFN against SARS-CoV virus is independent of MxA expression.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 049327928

Download citation: RISBibTeXText

PMID: 15651759


Related references

Potent inhibition of SARS-associated coronavirus infection and replication by type I interferons but not by type II interferon. Journal of Interferon & Cytokine Research 24(7): 388-390, 2004

Potent inhibition of SARS-associated coronavirus (SCOV) infection and replication by type I interferons (IFN-alpha/beta) but not by type II interferon (IFN-gamma). Journal of Interferon & Cytokine Research 24(7): 388-390, 2004

Inhibition of SARS coronavirus in vitro by human interferons. Antiviral Research 62(2): A59, 2004

Synergistic inhibition of SARS-coronavirus replication by type I and type II IFN. Advances in Experimental Medicine and Biology 581: 503-506, 2006

Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. Journal of Clinical Microbiology 43(7): 3054-3058, 2005

Anti-SARS virus antibody responses against human SARS-associated coronavirus and animal SARS-associated coronavirus-like virus. Chinese Medical Journal 117(11): 1723-1725, 2004

In vitro sensitivity of human metapneumovirus to type I interferons. Viral Immunology 24(2): 159-164, 2011

Type I and type II interferons upregulate functional type I interleukin-1 receptor in a human fibroblast cell line TIG-1. Journal of Interferon & Cytokine Research 15(12): 1065-1073, 1995

Differential gene induction by type I and type II interferons and their combination. Journal of Interferon and Cytokine Research 26(7): 462-472, 2006

Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histologic Features. Arthritis and Rheumatology 71(6): 1011-1021, 2019

Usutu virus growth in human cell lines: induction of and sensitivity to type I and III interferons. Journal of General Virology 94(Pt 4): 789-795, 2013

Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. Biomedical and Environmental Sciences 16(3): 246-255, 2003

Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. Plos Medicine 3(7): E237-E237, 2006

Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus. Journal of Virology 72(5): 4508-4514, 1998

Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells. Journal of Virology 82(1): 300-310, 2008